Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Rasha Khatib, Martin McKee, Harry Shannon, Clara Chow, Sumathy Rangarajan, Koon Teo, Li Wei, Prem Mony, Viswanathan Mohan, Rajeev Gupta, Rajesh Kumar, Krishnapillai Vijayakumar, Scott A Lear, Rafael Diaz, Alvaro Avezum, Patricio Lopez-Jaramillo, Fernando Lanas, Khalid Yusoff, Noorhassim Ismail, Khawar Kazmi, Omar Rahman, Annika Rosengren, Nahed Monsef, Roya Kelishadi, Annamarie Kruger, Thandi Puoane, Andrzej Szuba, Jephat Chifamba, Ahmet Temizhan, Gilles Dagenais, Amiram Gafni, Salim Yusuf

Open source

DOI
10.1016/s0140-6736(15)00469-9
Published
2016-01
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-15-00469-9,
  title = {Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data},
  author = {Rasha Khatib and Martin McKee and Harry Shannon and Clara Chow and Sumathy Rangarajan and Koon Teo and Li Wei and Prem Mony and Viswanathan Mohan and Rajeev Gupta and Rajesh Kumar and Krishnapillai Vijayakumar and Scott A Lear and Rafael Diaz and Alvaro Avezum and Patricio Lopez-Jaramillo and Fernando Lanas and Khalid Yusoff and Noorhassim Ismail and Khawar Kazmi and Omar Rahman and Annika Rosengren and Nahed Monsef and Roya Kelishadi and Annamarie Kruger and Thandi Puoane and Andrzej Szuba and Jephat Chifamba and Ahmet Temizhan and Gilles Dagenais and Amiram Gafni and Salim Yusuf},
  year = {2016},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(15)00469-9},
  url = {https://doi.org/10.1016/s0140-6736(15)00469-9}
}

RIS

TY  - JOUR
TI  - Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
AU  - Rasha Khatib
AU  - Martin McKee
AU  - Harry Shannon
AU  - Clara Chow
AU  - Sumathy Rangarajan
AU  - Koon Teo
AU  - Li Wei
AU  - Prem Mony
AU  - Viswanathan Mohan
AU  - Rajeev Gupta
AU  - Rajesh Kumar
AU  - Krishnapillai Vijayakumar
AU  - Scott A Lear
AU  - Rafael Diaz
AU  - Alvaro Avezum
AU  - Patricio Lopez-Jaramillo
AU  - Fernando Lanas
AU  - Khalid Yusoff
AU  - Noorhassim Ismail
AU  - Khawar Kazmi
AU  - Omar Rahman
AU  - Annika Rosengren
AU  - Nahed Monsef
AU  - Roya Kelishadi
AU  - Annamarie Kruger
AU  - Thandi Puoane
AU  - Andrzej Szuba
AU  - Jephat Chifamba
AU  - Ahmet Temizhan
AU  - Gilles Dagenais
AU  - Amiram Gafni
AU  - Salim Yusuf
PY  - 2016
JO  - The Lancet
DO  - 10.1016/s0140-6736(15)00469-9
UR  - https://doi.org/10.1016/s0140-6736(15)00469-9
ER  - 

APA

Khatib, R., McKee, M., Shannon, H., Chow, C., Rangarajan, S., Teo, K., Wei, L., Mony, P., Mohan, V., Gupta, R., Kumar, R., Vijayakumar, K., Lear, S. A., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., Yusoff, K., Ismail, N., Kazmi, K., Rahman, O., Rosengren, A., Monsef, N., Kelishadi, R., Kruger, A., Puoane, T., Szuba, A., Chifamba, J., Temizhan, A., Dagenais, G., Gafni, A., & Yusuf, S. (2016). Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet. https://doi.org/10.1016/s0140-6736(15)00469-9

Source records